We are live on
!
Find out more
XI
XXEC Inc Portfolio holdings
AUM
$571M
1-Year Est. Return
1.42%
This Fund
S&P 500
This Quarter
Est. Return
+5.6%
1 Year Est. Return
-1.42%
3 Year Est. Return
+24.23%
5 Year Est. Return
+35.66%
10 Year Est. Return
–
AUM
$132M
AUM Growth
+$2.85M
(+2.2%)
Cap. Flow
-$3.48M
Cap. Flow
% of AUM
-2.63%
Top 10 Holdings %
Top 10 Hldgs %
65.92%
Holding
23
New
–
Increased
8
Reduced
10
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teradyne
TER
|
+$4.04M |
| 2 |
Deere & Co
DE
|
+$2.26M |
| 3 |
Gentex
GNTX
|
+$1.39M |
| 4 |
Chubb
CB
|
+$1.16M |
| 5 |
Universal Display
OLED
|
+$513K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$4.75M |
| 2 |
Idexx Laboratories
IDXX
|
+$3.13M |
| 3 |
Bentley Systems
BSY
|
+$2.5M |
| 4 |
Mastercard
MA
|
+$2.34M |
| 5 |
Intuit
INTU
|
+$87.4K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 41.73% |
| 2 | Financials | 29.28% |
| 3 | Industrials | 17.8% |
| 4 | Healthcare | 7.32% |
| 5 | Consumer Discretionary | 3.86% |
Similar funds
RI
TWA
BSG
MW
MAM
FRM
NA
EHI
XXEC Inc's Q3 2024 Portfolio in Review
As of Q3 2024, XXEC Inc held 23 positions worth $132M, up 2.2% from $130M the previous quarter. Its ten largest holdings account for 66% of the portfolio.
XXEC Inc's Q3 2024 filing shows 8 increased, 10 reduced and 3 closed positions. The largest sale was Pfizer, an estimated $4.75M.
By sector, the portfolio is most concentrated in Technology at 42% of assets, up from 41% a quarter earlier, followed by Financials and Industrials.
- XXEC Inc added most to Teradyne in Q3 2024, an estimated $4.04M increase.
- XXEC Inc's biggest Q3 2024 reduction was Mastercard, cutting an estimated $2.34M.
- XXEC Inc fully exited Pfizer in Q3 2024, selling an estimated $4.75M.
- XXEC Inc's ten largest holdings make up 66% of its $132M portfolio in Q3 2024.
- XXEC Inc opened 0 new positions and closed 3 in Q3 2024.
- XXEC Inc's portfolio value rose 2.2% quarter-over-quarter to $132M.
Based on XXEC Inc's 13F filing for Q3 2024, filed 5 Nov 2024.